- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06024980
Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy (SPPDPL)
Department of Otolaryngology Head Neck Surg
Study Overview
Status
Conditions
Detailed Description
There were swallowing disorders after partial laryngectomy in most patients with laryngeal carcinoma. At least these patients need several months to recover. Few people required surgery of total laryngectomy to maintain normal swallowing function. The swallowing training cannot acquire a valid swallowing function and take the risk of aspiration pneumonia. Factors that influenced the swallowing function recovery, for example, the time of nasogastric feeding and tracheostomy tube removal, were affected by age and diabetes.
On the other hand, the pharynx size of a CT scan can predict the recovery of swallowing function after laryngectomy. But those are not directly related to swallowing motion, although they are predictors of dysphagia. The investigators will perform the study with swallowing function measures to find predictors relative to swallowing function and evaluate dysphagia's recovery early.
Subglottic pressure is a protective factor that can reduce aspiration risk. This research will measure the subglottic pressure after laryngectomy and predict or monitor swallowing disorders. Specific objectives were to verify the effect of laryngectomy on subglottic pressure.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Pingjiang Ge, M.D.
- Phone Number: +8613751753465
- Email: gepingjiang@aliyun.com
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510080
- Recruiting
- Guangdong Provincial People's Hospital
-
Contact:
- Pingjiang Ge
- Phone Number: +8613751753465
- Email: gepingjiang@aliyun.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: 18-80 years
- Surgical treatment by open partial horizontal laryngectomy type I or II and transoral laser cordectomy for squamous cell carcinoma
- Availability of clinical data
- Validity of normal swallowing of thin liquids
Exclusion Criteria:
- Presence of severe chronic obstructive pulmonary disease, severe heart disease, and psychopathy or mental disease
- Surgery complications(such as sepsis, pharyngocutaneous fistula, surgical revision)
- Radiotherapy histology
- Swallowing disorder or trachea aspiration before surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Supraglottic and glottic T2 laryngeal carcinoma
The open partial horizontal laryngectomy was underwent in patients with supraglottic or glottic laryngeal carcinoma in T2
|
An open partial horizontal laryngectomy(OPHL) was performed for patients with T2 supraglottic and glottic carcinoma, according to the American Joint Committee on Cancer(AJCC) criteria.
Type I OPHL: Entails the resection of the supraglottis, including the pre-epiglottic space and the upper half of the thyroid cartilage.
Type II OPHL: Entails the resection of the entire thyroid cartilage, with the inferior limit represented by the upper edge of the cricoid ring.
Type III OPHL: Entails the resection of the entire supraglottic, glottic, and part of the subglottic sites, sparing both or at least one functioning crico-arytenoid unit.
Other Names:
|
|
Active Comparator: Supraglottic and glottic T1 laryngeal carcinoma
The transoral endoscopic laser cordectomy was underwent in patients with supraglottic or glottic laryngeal carcinoma in T1
|
For patients with T1 glottic laryngeal carcinoma, according to the criteria of the American Joint Committee on Cancer(AJCC), transoral endoscopic CO2 laser(2-40Watts) cordectomy was performed. The classification comprises eight types of cordectomies:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fiberoptic laryngoscope evaluation of swallowing
Time Frame: Pre-operation, one week post-operation, two months post-operation, six months post-operation
|
The patient, in a sitting position, had to swallow liquid.
The tip of a flexible endoscope was positioned beyond the soft palate, and the pharyngeal phase of swallowing was studied, recording videos and images for further analysis.
In particular, according to the severity scale, the scores ranged from 1 point (no materials entered the airway) to 8 points (the material penetrated below the vocal cords, but no effort was made to eject the material), representing the severity of risk for penetration
|
Pre-operation, one week post-operation, two months post-operation, six months post-operation
|
|
direct subglottic pressure
Time Frame: At one day before surgery, one week after surgery, two months after surgery, six months after surgery
|
Subglottic pressure was measured while swallowing a thinned solution with and without airflow delivery through the subglottic puncture needle.
The unit of subglottic pressure is cmH20.
|
At one day before surgery, one week after surgery, two months after surgery, six months after surgery
|
|
EAT-10 questionnaire
Time Frame: At one day before surgery, two months after surgery, six months after surgery
|
The EAT-10 questionnaire consists of a 10-item questionnaire with a maximum total score of 40 points.
All items are rated on a 5-point scale in which 0 indicates no problem, and 4 indicates a severe problem in swallowing function.
An EAT-10 score of over 3 is abnormal and indicates a higher self-perception of the presence of dysphagia.
|
At one day before surgery, two months after surgery, six months after surgery
|
|
Swallowing ability to four different textures
Time Frame: At one day before surgery, one week after surgery, two months after surgery, six months after surgery
|
An early 5-point scoring system (score one corresponding to the early postoperative assessment) was applied to each patient depending on his ability to swallow one to four different textures (liquid, semi-liquid, semi-solid, and solid).
A score of 0 is poor (no power to swallow), while a score of 4 is good.
|
At one day before surgery, one week after surgery, two months after surgery, six months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Voice acoustic analysis
Time Frame: At one day before surgery, six months after surgery
|
Every participant was asked to phonate a sustained vowel /a/ at a habitual comfortable pitch and intensity for voice pitch, quality assessments, and habitual vocal intensity.
The recordings were made in a quiet clinical room.
The participant sat in front of a microphone positioned approximately 10cm from the left corner of the mouth.
The voice signal coupled with Roland's Audio interface with a sampling rate of 44k-Hz and 16-bit accuracy.
The signal was stored in a computer system after collecting sustained vowels.
The voice signals were analyzed using speech analysis software.
The stable phase of the voice sample was extracted for analysis.
The 3,000-msec sample was analyzed for acoustic parameters.
The voice acoustic parameters include F0 (fundamental frequency) in Hertz(Hz), percentage of jitter(%), percentage of shimmer(%), Harmonic to noise ratio(HNR), and intensity in decibels(dB).
|
At one day before surgery, six months after surgery
|
|
The time in weeks of nasogastric feeding
Time Frame: At two months after surgery, six months after surgery
|
The duration of surgery to oral feeding after withdrawing naso tube.
|
At two months after surgery, six months after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Xujiao Chen, Ms, Guangdong Provicial People's Hospital(Guangdong Academy of Sciences), Southern Medical University
Publications and helpful links
General Publications
- Bagwell K, Leder SB, Sasaki CT. Is partial laryngectomy safe forever? Am J Otolaryngol. 2015 May-Jun;36(3):437-41. doi: 10.1016/j.amjoto.2014.11.005. Epub 2014 Nov 20.
- Freitas AS, Santos IC, Furia C, Dornelas R, Silva ACAE, Dias FL, Salles GF. Prevalence and associated factors of aspiration and severe dysphagia in asymptomatic patients in the late period after open partial laryngectomy: a videofluoroscopic evaluation. Eur Arch Otorhinolaryngol. 2022 Jul;279(7):3695-3703. doi: 10.1007/s00405-021-07231-4. Epub 2022 Jan 4.
- Breunig C, Benter P, Seidl RO, Coordes A. Predictable swallowing function after open horizontal supraglottic partial laryngectomy. Auris Nasus Larynx. 2016 Dec;43(6):658-65. doi: 10.1016/j.anl.2016.01.003. Epub 2016 Feb 4.
- Dawson C, Pracy P, Patterson J, Paleri V. Rehabilitation following open partial laryngeal surgery: key issues and recommendations from the UK evidence based meeting on laryngeal cancer. J Laryngol Otol. 2019 Mar;133(3):177-182. doi: 10.1017/S0022215119000483.
- Clarett M, Andreu MF, Salvati IG, Donnianni MC, Montes GS, Rodriguez MG. [Effect of subglottic air insufflation on subglottic pressure during swallowing]. Med Intensiva. 2014 Apr;38(3):133-9. doi: 10.1016/j.medin.2013.01.003. Epub 2013 Mar 6. Spanish.
- Alaskarov E, Ozturk O, Batioglu-Karaaltin A, Gulmez ZD, Erdur ZB, Inan HC. Functional Outcomes of the Hyaluronic Acid Injections in Patients Who Underwent Partial Laryngectomy. J Voice. 2022 May;36(3):417-422. doi: 10.1016/j.jvoice.2020.06.026. Epub 2020 Jul 22.
- Fakhry N, Michel J, Giorgi R, Robert D, Lagier A, Santini L, Moreddu E, Puymerail L, Adalian P, Dessi P, Giovanni A. Analysis of swallowing after partial frontolateral laryngectomy with epiglottic reconstruction for glottic cancer. Eur Arch Otorhinolaryngol. 2014 Jul;271(7):2013-20. doi: 10.1007/s00405-013-2750-3. Epub 2013 Oct 8.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Respiratory Tract Diseases
- Neoplasms
- Neoplasms by Site
- Gastrointestinal Diseases
- Respiratory Tract Neoplasms
- Otorhinolaryngologic Neoplasms
- Head and Neck Neoplasms
- Pharyngeal Diseases
- Otorhinolaryngologic Diseases
- Esophageal Diseases
- Laryngeal Diseases
- Deglutition Disorders
- Laryngeal Neoplasms
Other Study ID Numbers
- 2022-59 (Ethique CVL)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laryngeal Cancer
-
University Hospital OstravaRecruitingLaryngeal Disease | Laryngeal Lesions | Hypopharyngeal Lesions | Suspected Laryngeal Cancer | Suspected Hypopharyngeal Cancer | Proven Laryngeal Cancer | Proven Hypopharyngeal CancerCzechia
-
Thomas Jefferson UniversityCompletedHead and Neck Carcinoma | Lung Carcinoma | Oral Cavity Carcinoma | Paranasal Sinus Carcinoma | Stage III Laryngeal Cancer AJCC v8 | Stage IV Laryngeal Cancer AJCC v8 | Hypopharyngeal Carcinoma | Laryngeal Carcinoma | Stage IVA Laryngeal Cancer AJCC v8 | Stage IVB Laryngeal Cancer AJCC v8 | Stage IVC Laryngeal... and other conditionsUnited States
-
Wake Forest University Health SciencesTerminatedHead and Neck Cancer | Stage I Laryngeal Cancer | Stage II Laryngeal Cancer | Stage I Hypopharyngeal Cancer | Stage I Oropharyngeal Cancer | Stage II Hypopharyngeal Cancer | Stage II Oropharyngeal Cancer | Stage III Hypopharyngeal Cancer | Stage III Laryngeal Cancer | Stage III Oropharyngeal Cancer | Stage... and other conditionsUnited States
-
Humanitas UniversityEnrolling by invitationLaryngeal Cancer | Laryngeal CarcinomaItaly
-
Centre Hospitalier Universitaire de NīmesCompleted
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Zhongda Hospital; Nanjing Children's Hospital; Shanghai Ninth People's Hospital... and other collaboratorsNot yet recruitingHead and Neck Cancer | Laryngeal Cancer | Hypopharyngeal CancerChina
-
Eye & ENT Hospital of Fudan UniversityNot yet recruitingLaryngeal Cancer | Difficult Airway
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingHead and Neck Neoplasms | Carcinoma, Squamous Cell | Laryngeal Cancer Stage II | Laryngeal Cancer Stage IIINetherlands
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage III Laryngeal Cancer AJCC v8 | Laryngeal Squamous Cell Carcinoma | Stage II Laryngeal Cancer AJCC v8United States
-
First Affiliated Hospital, Sun Yat-Sen UniversityUnknownRecurrent Laryngeal CancerChina